Breast Cancer
Latest News
Bariatric Surgery May Reduce Breast Cancer Risk for Some
“The surgical treatment benefit was predominantly seen in women with hyperinsulinemia, suggesting insulin may be used as a predictor of treatment...
Conference Coverage
Carefully Designing De-escalation Trials in Breast Cancer
Doctors highlight several strategies for designing de-escalation trials.
Feature
ADCs for Breast Cancer: Clear Benefits, Manageable Risks
The latest data on several ADCs — their clinical benefit and safety — were the focus of three presentations at the ESMO Breast Cancer Annual...
Feature
The ASCO Annual Meeting Starts This Week
More than 7000 abstracts were submitted for this year’s meeting a new record — and over 5000 were selected for presentation.
Latest News
Exercise Improves Sexual Health in Women With Metastatic Breast Cancer
Physical activity improved sexual health, fatigue, and quality of life.
From the Journals
ASTRO Releases New EBRT Guideline for Symptomatic Bone Mets
Recommendations concerning pain management and quality of life are part of the guidance.
From the Journals
ASCO Provides Guidance on CDK4/6 Inhibitors for Early Breast Cancer
A guideline update incorporates new high-quality evidence for the adjuvant use of CDK4/6 inhibitors in early breast cancer.
Latest News
Clinicians Face Hurdles in Caring for the Growing Number of Cancer Survivors
Primary care clinicians must help patients with new health problems that emerge as the result of previous cancer treatments and with side effects...
Feature
Obesity and Cancer: Untangling a Complex Web
Is gaining weight later in life better or worse for cancer risk than being overweight or obese from a young age?
Conference Coverage
Most women can conceive after breast cancer treatment
In a modern cohort of patients under 40 without metastatic disease, financial status and egg or embryo freezing — but not chemotherapy — affected...
Latest News
Is Vaginal Estrogen Safe in Breast Cancer Survivors?
Study results suggest that estrogen therapy “is safe in individuals with HR-negative tumors and in those concurrently treated with tamoxifen.”